Lyra Therapeutics
LYRA
LYRA
78 hedge funds and large institutions have $283M invested in Lyra Therapeutics in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
30% more funds holding
Funds holding: 60 → 78 (+18)
28% more capital invested
Capital invested by funds: $222M → $283M (+$61.4M)
0.09% less ownership
Funds ownership: 1.61% → 1.53% (-0.09%)
Holders
78
Holding in Top 10
3
Calls
$1.87M
Puts
$8K
Top Buyers
1 | +$9.19M | |
2 | +$6.24M | |
3 | +$6.09M | |
4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$4.78M |
5 |
LCM
Laurion Capital Management
New York
|
+$4.39M |
Top Sellers
1 | -$13.7M | |
2 | -$7.65M | |
3 | -$5.7M | |
4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$4.63M |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.6M |